Evidence map›Paper›PMID 38215155›Full record

ArticlePLoS pathogens2024

Transcriptome and small RNAome profiling uncovers how a recombinant begomovirus evades RDRγ-mediated silencing of viral genes and outcompetes its parental virus in mixed infection.

Margaux Jammes, Victor Golyaev, Alejandro Fuentes, Nathalie Laboureau, Cica Urbino, Clemence Plissonneau, Michel Peterschmitt, Mikhail M Pooggin

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
7.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. ACS infectious diseases · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Margaux JammesPHIM Plant Health Institute, University Montpellier, CIRAD, INRAE, IRD, Institute Agro, Montpellier, France.
Victor GolyaevPHIM Plant Health Institute, University Montpellier, CIRAD, INRAE, IRD, Institute Agro, Montpellier, France.
Alejandro FuentesCenter for Genetic Engineering and Biotechnology, Habana, Cuba.
Nathalie LaboureauPHIM Plant Health Institute, University Montpellier, CIRAD, INRAE, IRD, Institute Agro, Montpellier, France.
Cica UrbinoPHIM Plant Health Institute, University Montpellier, CIRAD, INRAE, IRD, Institute Agro, Montpellier, France.
Clemence PlissonneauGAUTIER Semences, Route d'Avignon, Eyragues, France.
Michel PeterschmittPHIM Plant Health Institute, University Montpellier, CIRAD, INRAE, IRD, Institute Agro, Montpellier, France.
Mikhail M PoogginPHIM Plant Health Institute, University Montpellier, CIRAD, INRAE, IRD, Institute Agro, Montpellier, France.ORCID 0000-0003-2308-393X
Centre de Coopération Internationale en Recherche Agronomique pour le Développement · FRCentro de Ingeniería Genética y Biotecnología · CU

Funding

CIRAD South action travel grantPRIMA project “Prevention and control of new and invasive geminiviruses infecting vegetables in the Mediterranean”
6 · The paper itself

Abstract

Tomato yellow leaf curl virus (TYLCV, genus Begomovirus, family Geminiviridae) causes severe disease of cultivated tomatoes. Geminiviruses replicate circular single-stranded genomic DNA via rolling-circle and recombination-dependent mechanisms, frequently generating recombinants in mixed infections. Circular double-stranded intermediates of replication also serve as templates for Pol II bidirectional transcription. IS76, a recombinant derivative of TYLCV with a short sequence in the bidirectional promoter/origin-of-replication region acquired from a related begomovirus, outcompetes TYLCV in mixed infection and breaks disease resistance in tomato Ty-1 cultivars. Ty-1 encodes a γ-clade RNA-dependent RNA polymerase (RDRγ) implicated in Dicer-like (DCL)-mediated biogenesis of small interfering (si)RNAs directing gene silencing. Here, we profiled transcriptome and small RNAome of Ty-1 resistant and control susceptible plants infected with TYLCV, IS76 or their combination at early and late infection stages. We found that RDRγ boosts production rates of 21, 22 and 24 nt siRNAs from entire genomes of both viruses and modulates DCL activities in favour of 22 and 24 nt siRNAs. Compared to parental TYLCV, IS76 undergoes faster transition to the infection stage favouring rightward transcription of silencing suppressor and coat protein genes, thereby evading RDRγ activity and facilitating its DNA accumulation in both single and mixed infections. In coinfected Ty-1 plants, IS76 efficiently competes for host replication and transcription machineries, thereby impairing TYLCV replication and transcription and forcing its elimination associated with further increased siRNA production. RDRγ is constitutively overexpressed in Ty-1 plants, which correlates with begomovirus resistance, while siRNA-generating DCLs (DCL2b/d, DCL3, DCL4) and genes implicated in siRNA amplification (α-clade RDR1) and function (Argonaute2) are upregulated to similar levels in TYLCV- and IS76-infected susceptible plants. Collectively, IS76 recombination facilitates replication and promotes expression of silencing suppressor and coat proteins, which allows the recombinant virus to evade the negative impact of RDRγ-boosted production of viral siRNAs directing transcriptional and posttranscriptional silencing.

Indexed as

BegomovirusCoinfectionSolanum lycopersicumDNAGenes, ViralPlant DiseasesRNA, Double-StrandedRNA, Small InterferingTranscriptomeDNARNA, Double-StrandedRNA, Small Interfering

Identifiers

PMID38215155
PMCPMC10810479
OpenAlexW4390825371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.